logo

For the Inventor, By the Inventor

Ageo, Japan

Sakae Takaku

USPTO Granted Patents = 10

Average Co-Inventor Count = 7.0

ph-index = 4

Forward Citations = 67(Granted Patents)


Location History:

  • Ageo, JA (1976 - 1978)
  • Ageo, JP (1980 - 1982)
  • Saitama, JP (1991)
  • Saitama-ken, JP (1996)

Company Filing History:

goldMedal10 out of 950 
 
Chugai Seiyaku Kabushiki Kaisha
 patents

Years Active: 1976-1996

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5563258 - Sucralfate aqueous suspension and its method of preparation (1996-10-08),
2. 5019574 - 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline (1991-05-28),
3. 4366161 - Nicotinamide derivative, process for preparing the same and (1982-12-28),
4. 4361572 - Tetrahydronicotinamide derivative, pharmaceutical compositions and use (1982-11-30),
5. 4221814 - Terephthalic acid monoamide derivatives, process for preparing the same, (1980-09-09),
6. 4200640 - Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use (1980-04-29),
7. 4092431 - Pharmaceutical composition and method of the use thereof (1978-05-30),
8. 4058523 - Bis(benzamido)-benzene derivatives (1977-11-15),
9. 4038416 - Pharmaceutical composition and method of the use thereof (1977-07-26),
10. 3953496 - Bis(benzamido)-benzoic acid derivatives (1976-04-27),

Title: Inventions and Innovations of Sakae Takaku

Introduction

Sakae Takaku, based in Ageo, Japan, is a prominent inventor with an impressive portfolio of ten patents. His work primarily focuses on advancements in pharmaceutical compositions, showcasing his commitment to improving healthcare through innovative solutions.

Latest Patents

Among his most notable patents is the development of a sucralfate aqueous suspension and its method of preparation. This new production process allows for the direct dispersal of sucralfate particles in water or other aqueous mediums, contrasting with traditional methods that require drying. This innovation not only maintains the effectiveness of the pharmaceutical but also enhances environmental sustainability by reducing pollution associated with conventional production processes.

Another significant contribution from Takaku includes the research on 3,4-diaminoquinoline and related compounds. These 4-aminopyridine derivatives are pivotal in creating pharmaceutical compositions aimed at elevating psychoneural functions, particularly in treating Alzheimer-type dementia, thus promoting memory and learning capabilities.

Career Highlights

Currently, Sakae is associated with Chugai Seiyaku Kabushiki Kaisha, where he continues to innovate and contribute to the field of pharmaceuticals. His dedication to research and development has established him as a respected figure within the industry, influencing practices and products that significantly impact patient care.

Collaborations

Throughout his career, Takaku has collaborated with several notable colleagues, including fellow inventors Shigeyuki Kataoka and Minoru Shindo. These partnerships have fostered an environment of shared knowledge and creativity, driving forward the boundaries of medical science and innovation.

Conclusion

Sakae Takaku's contributions to the field of pharmaceuticals through his inventive spirit and dedication are exemplary. With a firm foundation of ten patents, his work not only enhances the efficacy of treatments but also promotes a more sustainable approach to pharmaceutical production. His ongoing endeavors continue to inspire future generations of inventors striving to create impactful innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…